Inhibition of insulin-like growth factor-1 receptor signaling enhances growth-inhibitory and proapoptotic effects of gefitinib (Iressa) in human breast cancer cells
-
* Corresponding author: Michael Pollak michael.pollak@mcgill.ca
Breast Cancer Research 2005, 7:R570-R579 doi:10.1186/bcr1028
Accesses
- Last 30 days: 86 accesses
- Last year: 843 accesses
- All time: 7357 accesses
Cited by
BioMed Central: 3 citations
|
Research article
Robert K Dearth, Isere Kuiatse, Yu-Fen Wang, Lan Liao, Susan G Hilsenbeck, Powel H Brown, Jianming Xu, Adrian V Lee BMC Cancer 2011, 11:377 (25 August 2011) |
|
Research article
Dana Inbar-Rozensal, Asher Castiel, Leonid Visochek, David Castel, Françoise Dantzer, Shai Izraeli, Malka Cohen-Armon Breast Cancer Research 2009, 11:R78 (9 November 2009) Phenanthridine derived polyADP-ribose polymerase (PARP) inhibitors originally designed to protect cells from cell-death under stress conditions efficiently eradicate breast cancer cells without impairing normal proliferating or non-proliferating cells.
|
|
Research article
Joanna Lisztwan, Astrid Pornon, Bin Chen, Shiuan Chen, Dean B Evans Breast Cancer Research 2008, 10:R56 (8 July 2008) |